{"id":"NCT01675635","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","briefTitle":"OxyNorm Capsules in Post-Operative Pain Study","officialTitle":"A Double-blind, Randomized, Parallel Group Study to Compare the Efficacy and Safety, of Oxycodone Immediate-release Capsules Versus Morphine Immediate-release Tablets in Hospitalized Patients With Moderate to Severe Pain Following Surgery.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2012-06","completion":"2012-07","firstPosted":"2012-08-30","resultsPosted":"2018-02-26","lastUpdate":"2018-02-26"},"enrollment":240,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Postoperative Pain"],"interventions":[{"type":"DRUG","name":"OxyNorm Capsules","otherNames":["OxyNorm"]},{"type":"OTHER","name":"Morphine tablet","otherNames":["Morphine"]}],"arms":[{"label":"OxyNorm Capsules","type":"EXPERIMENTAL"},{"label":"Morphine tablet","type":"ACTIVE_COMPARATOR"}],"summary":"The efficacy and safety of oxycodone capsules compared with morphine tablets in hospitalized patients with moderate to severe pain following surgery.","primaryOutcome":{"measure":"Visual Analogue Scale (VAS) in Resting Stage at 6hour (6hour±20 Minutes After Administration of First Dose)","timeFrame":"Baseline and 6h (±20min)","effectByArm":[{"arm":"OxyNorm Capsules","deltaMin":46.21,"sd":9.53},{"arm":"Morphine Tablet","deltaMin":45.48,"sd":7.94}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":117},"commonTop":["Nausea","Vomiting","Dizziness","abdominal distension","postoperative infection"]}}